논문KCI 등재
Can SAFE score be utilized as a universal hepatocellu lar carcinoma prediction score?: Editorial on “High Steatosis-Associated Fibrosis Estimator scores pre dict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated stea totic liver disease”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on “High Steatosis-Associated Fibrosis Esti mator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-as sociated steatotic liver disease”Ho Soo Chun, Minjong Lee대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호HCC predictors in routine practice for patients with chronic liver diseases: Correspondence to editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunc tion associated steatotic liver disease”Jia-Horng Kao, Tung-Hung Su대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver diseaseChe Lin, Fen-Fang Chen, Francis SK Poon, Jia-Horng Kao, Lung-Wen Tsai, Mei-Hsuan Lee, Shang-Chin Huang, Sheng-Shun Yang, Tung-Hung Su, Weichung Wang, Wei-Yu Kao, W Ray Kim, Yi-Ting Chen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients: Editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”Emmanuel A. Tsochatzis, Mirko Zoncapè대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunc tion-associated steatotic liver disease”Hye Won Lee, Seung Up Kim대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Risk stratification of metabolic dysfunction-associated steatotic liver disease: The KASL pathway: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”Jarell Jie-Rae Tan, May Xuan Goh, Vincent L Chen, Xin En Goh, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12